Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.16% | 10.39% | 4.81% | -1.00% | -1.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.16% | 10.39% | 4.81% | -1.00% | -1.45% |
| Cost of Revenue | 10.78% | 7.72% | 6.67% | -1.17% | -2.91% |
| Gross Profit | 13.49% | 12.83% | 3.48% | -0.87% | 0.00% |
| SG&A Expenses | 12.59% | 8.67% | 12.99% | 1.19% | 2.44% |
| Depreciation & Amortization | 6.92% | 5.26% | 3.82% | -3.76% | -5.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.13% | 7.25% | 8.14% | 0.00% | -1.37% |
| Operating Income | 85.71% | 640.00% | -26.09% | -9.02% | -6.67% |
| Income Before Tax | -407.84% | -108.94% | 178.13% | 400.00% | 59.84% |
| Income Tax Expenses | 139.53% | -108.21% | -22.22% | 65.00% | -407.14% |
| Earnings from Continuing Operations | -3,350.00% | -109.34% | 122.00% | 109.38% | 94.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,350.00% | -109.34% | 122.00% | 109.38% | 94.33% |
| EBIT | 85.71% | 640.00% | -26.09% | -9.02% | -6.67% |
| EBITDA | 15.48% | 25.81% | -7.87% | -5.54% | 27.27% |
| EPS Basic | -3,328.40% | -109.29% | 121.94% | 108.47% | 94.34% |
| Normalized Basic EPS | -28.96% | 61.06% | -46.13% | 18.50% | 44.18% |
| EPS Diluted | -2,758.67% | -109.59% | 119.76% | 116.67% | 93.26% |
| Normalized Diluted EPS | -28.96% | 60.82% | -46.46% | 18.19% | 44.18% |
| Average Basic Shares Outstanding | 0.51% | 0.51% | 0.49% | 0.39% | 0.32% |
| Average Diluted Shares Outstanding | 0.51% | -0.18% | 1.19% | 0.63% | 0.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |